hill nonlinear variable slope model Search Results


non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software
Non Linear Dose–Response Curve Fitting Analyses Via Graphpad Prism V. 2.01 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear dose–response curve fitting analyses via graphpad prism v. 2.01 software - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
log (agonist) versus normalized-response (variable slope) nonlinear regression model  (GraphPad Software Inc)
90
GraphPad Software Inc log (agonist) versus normalized-response (variable slope) nonlinear regression model
Log (Agonist) Versus Normalized Response (Variable Slope) Nonlinear Regression Model, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/log (agonist) versus normalized-response (variable slope) nonlinear regression model/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
log (agonist) versus normalized-response (variable slope) nonlinear regression model - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
nonlinear regression to a normalized variable slope model in graphpad prism 9  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear regression to a normalized variable slope model in graphpad prism 9
Nonlinear Regression To A Normalized Variable Slope Model In Graphpad Prism 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression to a normalized variable slope model in graphpad prism 9/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression to a normalized variable slope model in graphpad prism 9 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
prism 9 nonlinear regression fit modelling variable slope  (GraphPad Software Inc)
90
GraphPad Software Inc prism 9 nonlinear regression fit modelling variable slope
Prism 9 Nonlinear Regression Fit Modelling Variable Slope, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism 9 nonlinear regression fit modelling variable slope/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism 9 nonlinear regression fit modelling variable slope - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0  (GraphPad Software Inc)
90
GraphPad Software Inc curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Curves Generated From Raw Fluorescence Data Using A 4 Parameter Variable Slope Hill Model In Graphpad Prism 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
curves generated from raw fluorescence data using a 4-parameter variable-slope hill model in graphpad prism 7.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
4-parameter variable-slope hill model in graphpad prism 8.0  (GraphPad Software Inc)
90
GraphPad Software Inc 4-parameter variable-slope hill model in graphpad prism 8.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
4 Parameter Variable Slope Hill Model In Graphpad Prism 8.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4-parameter variable-slope hill model in graphpad prism 8.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
4-parameter variable-slope hill model in graphpad prism 8.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
nonlinear regression analysis modeled with a sigmoid curve with variable slope prism 4.0  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear regression analysis modeled with a sigmoid curve with variable slope prism 4.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Nonlinear Regression Analysis Modeled With A Sigmoid Curve With Variable Slope Prism 4.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression analysis modeled with a sigmoid curve with variable slope prism 4.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression analysis modeled with a sigmoid curve with variable slope prism 4.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
nonlinear regression curve fit with variable slope model by graphpad prism version 8.0.2  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear regression curve fit with variable slope model by graphpad prism version 8.0.2
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Nonlinear Regression Curve Fit With Variable Slope Model By Graphpad Prism Version 8.0.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression curve fit with variable slope model by graphpad prism version 8.0.2/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression curve fit with variable slope model by graphpad prism version 8.0.2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
built-in variable slope model graphpad prism 6  (GraphPad Software Inc)
90
GraphPad Software Inc built-in variable slope model graphpad prism 6
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Built In Variable Slope Model Graphpad Prism 6, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/built-in variable slope model graphpad prism 6/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
built-in variable slope model graphpad prism 6 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
nonlinear regression least square method in the variable slope model graphpad prism 7.0  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear regression least square method in the variable slope model graphpad prism 7.0
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Nonlinear Regression Least Square Method In The Variable Slope Model Graphpad Prism 7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression least square method in the variable slope model graphpad prism 7.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression least square method in the variable slope model graphpad prism 7.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
nonlinear fit variable slope model graphpad software  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear fit variable slope model graphpad software
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Nonlinear Fit Variable Slope Model Graphpad Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear fit variable slope model graphpad software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear fit variable slope model graphpad software - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
non-linear regression analysis and curve fitting parameters (four-parameter variable-slope nonlinear regression model)  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear regression analysis and curve fitting parameters (four-parameter variable-slope nonlinear regression model)
Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.
Non Linear Regression Analysis And Curve Fitting Parameters (Four Parameter Variable Slope Nonlinear Regression Model), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression analysis and curve fitting parameters (four-parameter variable-slope nonlinear regression model)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression analysis and curve fitting parameters (four-parameter variable-slope nonlinear regression model) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.

Journal: Toxicological Sciences

Article Title: Nonionic Ethoxylated Surfactants Induce Adipogenesis in 3T3-L1 Cells

doi: 10.1093/toxsci/kfx234

Figure Lengend Snippet: Ethoxylated Surfactants May Promote Adipogenesis via Inhibition of TRβ. Antagonist activity for the TRβ as measured via FRET reporter gene assay using the TRβ GeneBLAzer Reporter Assay as described in the Methods. Percent agonist TRβ activity for the T3 positive control relative to its maximum response (A), percent TRβ antagonism of intra-assay EC80 T3 (concentration that exhibits 80% of maximum T3 response; 0.3 nM) for various alkyl chain length ethoxylated surfactants (B), inhibition or enhancement of cell viability relative to vehicle control for various alkyl chain length ethoxylated surfactants (C), percent TRβ antagonism relative to intra-assay EC80 T3 for various ethoxylate chain length NPEOs (D), and inhibition or enhancement of cell viability relative to vehicle control for various ethoxylate chain length NPEOs (E). Data presented as mean ± SEM from 3 independent experiments. * indicates lowest concentration with significant antagonist activity relative to EC80 T3, p < .05, as per 1-way ANOVA and Dunnett’s posthoc test in GraphPad Prism 7.0.

Article Snippet: EC20/50 values were estimated using curves generated from raw fluorescence data using a 4-parameter variable-slope Hill model in GraphPad Prism 7.0.

Techniques: Inhibition, Activity Assay, Reporter Gene Assay, Reporter Assay, Positive Control, Intra Assay, Concentration Assay